ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
2,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
5,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
6,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
9,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9,2,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
9,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
9,4,Nail dystrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
9,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
9,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
9,7,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
9,8,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
10,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
13,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
15,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
16,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
16,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
16,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
16,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
16,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,8,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
17,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
18,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
20,1,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
21,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
21,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
22,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
22,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
23,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
23,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
24,3,Coma,Coma states,Neurological disorders NEC,Nerv,Y
25,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
26,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
28,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
28,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
29,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
30,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
31,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
32,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
32,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
32,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
34,1,Deafness,Hearing losses,Hearing disorders,Ear,N
35,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
35,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
36,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
36,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
37,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
38,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
38,4,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
38,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
40,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
40,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
40,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,6,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
41,1,Headache,Headaches NEC,Headaches,Nerv,N
41,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
42,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
42,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
42,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
43,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
43,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,Y
44,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
45,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
46,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
49,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
49,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
49,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
49,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
49,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
51,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
51,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
51,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
51,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
51,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
52,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
53,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
53,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
54,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
55,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
56,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
56,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
57,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
59,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
60,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
61,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
62,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
62,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
62,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
62,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
63,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
63,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
63,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
64,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
66,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
66,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
69,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
70,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
72,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
72,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
72,3,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
73,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
74,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
75,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
76,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
77,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
77,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
78,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
78,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
78,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
78,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
81,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
81,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
82,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
82,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
83,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
83,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
84,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
84,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
85,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
87,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
88,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Congenital jaw malformation,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
89,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
89,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
90,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
90,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
92,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
93,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
94,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
94,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
94,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
94,4,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
94,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
95,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
95,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
96,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
97,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
98,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
98,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
99,1,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
100,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
100,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
101,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
102,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
103,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
103,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
105,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
105,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
105,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
109,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
109,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
109,3,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
109,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
111,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
111,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
112,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
112,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
113,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
114,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
115,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
117,1,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
118,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
119,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
121,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
122,1,Deafness,Hearing losses,Hearing disorders,Ear,N
122,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
123,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
124,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
124,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
125,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
126,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
127,1,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
127,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
128,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
128,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
129,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
130,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
130,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
131,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
132,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
133,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
133,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
134,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
134,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
135,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
136,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
137,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
137,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
137,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
138,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
138,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
139,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
140,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
140,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
140,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
141,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
142,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
143,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
144,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
145,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
146,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
147,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
148,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
149,1,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
149,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
149,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
150,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
150,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
150,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
151,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
152,1,Lymphocytic leukaemia,Leukaemias lymphocytic NEC,Leukaemias,Neopl,N
153,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
153,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
153,3,Headache,Headaches NEC,Headaches,Nerv,N
154,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
154,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
154,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
155,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
157,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
158,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
159,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
160,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
160,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
161,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
162,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
162,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
163,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
164,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
165,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
165,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
165,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
165,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
165,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
166,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
167,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
168,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
168,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
169,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
170,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
172,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
173,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
173,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
173,3,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
173,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
175,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
176,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
176,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
177,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
178,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
179,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
180,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
180,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
180,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
181,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
181,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
181,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
181,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
182,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
183,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
184,1,Atrophie blanche,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
184,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
184,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
184,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
185,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
185,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
186,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
187,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
188,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
189,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
189,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
190,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
190,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
190,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
192,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
193,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
193,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
193,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
193,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
193,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
193,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
193,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
193,8,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
193,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
194,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
195,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
195,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
195,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
196,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
197,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
197,2,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
198,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
198,2,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
199,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
199,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
199,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
199,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
200,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
201,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
201,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
202,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
203,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
204,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
205,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
206,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
207,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
207,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
207,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
207,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
208,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
209,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
209,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
209,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
209,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
209,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
209,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
209,8,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
210,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
211,1,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
212,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
213,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
213,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
214,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
215,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
215,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
215,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
216,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
217,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
218,1,Atrophie blanche,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
218,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
218,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
218,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
218,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
218,6,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
218,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
218,8,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
218,9,Xerosis,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
219,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
221,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
221,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
221,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
222,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
222,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
222,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
222,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
222,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
223,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
223,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
223,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
224,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
225,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
225,2,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
226,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
226,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
227,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
228,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
228,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
229,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
230,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
231,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
231,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
232,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
233,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
233,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
234,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
234,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
234,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
234,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
235,1,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
236,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
238,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
239,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
239,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
239,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,4,Headache,Headaches NEC,Headaches,Nerv,N
239,5,Painful respiration,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
239,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
240,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
240,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
241,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
241,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
241,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
241,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
242,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
243,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
243,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
244,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
245,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
245,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,3,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
245,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
245,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
246,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
247,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
247,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
247,3,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
247,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
247,5,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
247,6,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
248,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
248,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
249,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
249,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
250,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
251,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
252,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
252,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
252,3,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
252,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
253,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
253,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
253,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
254,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
254,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
254,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
255,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
256,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
257,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
257,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
257,3,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
257,4,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
257,5,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
257,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
257,7,Neutrophil hypersegmented morphology present,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
257,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
258,1,Microcytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
258,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
259,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
259,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
259,4,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
259,5,Granuloma,Inflammations,General system disorders NEC,Genrl,N
259,6,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
259,7,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
259,8,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
259,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
259,10,Vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
260,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
260,2,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
260,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
260,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
261,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
262,1,Urethral cancer,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
263,1,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
264,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
264,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
265,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
265,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
265,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
265,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
265,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
265,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
265,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
266,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
267,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
267,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
267,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
268,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
269,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
270,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
271,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
272,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
272,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
272,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
272,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
273,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
274,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
276,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
276,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
276,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
277,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
278,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
279,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
280,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
281,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
281,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
281,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
282,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
282,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
282,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
282,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
283,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
283,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
283,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
284,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
285,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
286,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
287,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
287,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
287,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
288,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
289,1,Hypercoagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
289,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
289,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
289,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
290,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
291,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
291,2,Chronic myeloid leukaemia transformation,Leukaemias chronic myeloid,Leukaemias,Neopl,N
291,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
292,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
292,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
292,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
292,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
292,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
292,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
292,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
292,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
292,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
294,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
295,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
296,1,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
296,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
296,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
296,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
296,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
296,6,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
296,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
296,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
296,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
296,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
297,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
297,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
298,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
298,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
298,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
300,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
300,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
301,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
301,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
302,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
303,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
303,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
304,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
304,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
305,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
305,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
306,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
306,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
306,3,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
307,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
307,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
308,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
309,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
309,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
310,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
310,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
310,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
310,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
310,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
311,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
311,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
312,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
312,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
312,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
312,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
313,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
313,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
314,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
314,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
315,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
316,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
317,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
317,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
318,1,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
318,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
319,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
319,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
320,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
320,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
321,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
321,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
322,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
322,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
323,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
323,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
324,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
324,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
325,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
325,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
326,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
326,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
327,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
328,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
328,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
328,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
329,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
330,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
330,2,Pregnancy with injectable contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
330,3,Uterine dilation and curettage,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
331,1,Atrioventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
331,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
331,3,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
332,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
332,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
332,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
332,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
332,5,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
332,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
332,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
333,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
335,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
335,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
336,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
337,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
338,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
338,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
338,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
339,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
339,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
340,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
340,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
340,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
341,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
341,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
341,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
341,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
343,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
343,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
343,3,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
344,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
345,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
345,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
345,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
345,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
346,1,Gastrectomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
346,2,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
346,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
347,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
347,2,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
347,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
347,4,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
347,5,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
347,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
347,7,Sickle cell anaemia,Haemoglobinopathies congenital,Blood and lymphatic system disorders congenital,Cong,N
348,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
349,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
350,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
350,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
352,2,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
353,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
353,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
353,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
353,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
353,5,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
353,6,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
353,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
354,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
355,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
355,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
355,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
356,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
356,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
356,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
356,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
357,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
357,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
357,4,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
357,5,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
357,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
357,7,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
357,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
357,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
357,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
357,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
357,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
357,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
357,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
357,15,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
357,16,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
358,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
358,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
358,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
359,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
359,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
359,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
359,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
360,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
360,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
360,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
361,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
361,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
361,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
361,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
362,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
362,2,Advanced systemic mastocytosis,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
362,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
362,4,Blast cell count increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
362,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
362,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
362,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
362,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
362,9,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
363,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
363,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
363,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
363,5,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,6,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
364,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
364,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
366,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
366,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
367,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
367,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
368,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
369,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
369,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
369,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
370,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
371,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
372,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
372,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
373,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
373,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
374,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
374,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
374,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
375,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
375,2,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
376,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
377,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
377,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
377,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
378,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
378,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
378,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
378,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
380,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
380,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
381,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
381,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
381,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
381,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
381,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
382,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
382,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
383,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
384,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
385,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
385,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
385,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
386,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
387,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
387,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
388,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
388,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
388,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
389,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
389,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
390,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
390,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
390,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
391,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
391,2,Essential thrombocythaemia,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
392,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
392,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
393,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
393,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
393,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
394,1,Aquagenic pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
394,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
394,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
394,4,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
394,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
394,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
394,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
394,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
394,9,Serum ferritin decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
394,10,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
395,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
397,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
397,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
398,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
398,2,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
399,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
400,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
400,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
401,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
401,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
401,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
401,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
402,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
403,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
404,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
404,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
404,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
405,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
405,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
405,5,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
405,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
406,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
406,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
406,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
406,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
407,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
407,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
407,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
408,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
408,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
408,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
408,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
408,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
409,1,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
409,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
410,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
410,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
410,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
411,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
411,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
412,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
412,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
412,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
412,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
412,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
413,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
413,2,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
413,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
413,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
415,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
416,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
416,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
416,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
417,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
418,1,Headache,Headaches NEC,Headaches,Nerv,N
419,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
419,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
419,3,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
419,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
419,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
420,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
421,1,Headache,Headaches NEC,Headaches,Nerv,N
421,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
422,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
422,2,Haematocrit increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
422,3,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
422,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
423,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
424,1,Headache,Headaches NEC,Headaches,Nerv,N
425,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
425,2,Basophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
425,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,4,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
425,5,Headache,Headaches NEC,Headaches,Nerv,N
425,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
425,7,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
425,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
425,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
425,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
425,11,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
425,12,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
425,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
426,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
426,2,Differential white blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
426,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
426,4,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
426,5,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
426,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
426,7,Sickle cell anaemia,Haemoglobinopathies congenital,Blood and lymphatic system disorders congenital,Cong,N
427,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
427,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
428,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
428,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
429,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
429,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
430,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
430,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
431,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
431,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
432,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
433,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
433,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
433,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
433,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
433,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
434,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
435,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
436,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
437,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
438,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
439,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
440,1,Headache,Headaches NEC,Headaches,Nerv,N
440,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
441,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
442,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
443,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
444,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
445,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
446,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
447,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
448,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
449,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
449,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
450,1,Headache,Headaches NEC,Headaches,Nerv,N
450,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
451,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
451,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
452,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
453,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
454,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
454,2,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
454,3,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
455,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
455,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
455,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
455,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
455,5,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
455,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
455,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
456,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
457,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
457,2,Headache,Headaches NEC,Headaches,Nerv,N
458,1,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
459,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
459,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
460,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
461,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
461,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
461,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
461,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
461,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
461,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
462,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
463,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
463,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
464,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
465,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
466,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
466,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
466,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
466,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
466,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
466,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
467,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
467,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
467,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
468,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
468,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
469,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
470,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
471,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
471,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
471,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
471,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
472,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
473,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
474,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
475,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
476,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
477,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
478,1,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
479,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
479,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
480,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
481,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
482,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,Y
483,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
483,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
483,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
483,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
484,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
484,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
484,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
485,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
485,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
485,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
486,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
487,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
487,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
487,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
487,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
487,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
487,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
487,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
488,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
490,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
491,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
492,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
493,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
494,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
494,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
494,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
494,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
494,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
494,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
494,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
495,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
496,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
497,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
498,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
499,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
500,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
501,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
502,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
